APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK Cells

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NK Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchNK Cells Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cells Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NK Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cells Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cells Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global NK Cells market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NK Cells include Affimed NV, Altor BioScience, Chipscreen Biosciences, Fortress Biotech, Henry Ford Health Services, Innate Pharma, NantKwest, NKT and Sorrento Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NK Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NK Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NK Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NK Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

NK Cells Segment by Company

Affimed NV

Altor BioScience

Chipscreen Biosciences

Fortress Biotech

Henry Ford Health Services

Innate Pharma

NantKwest

NKT

Sorrento Therapeutics

Bristol-Myers Squibb

Takeda

NK Cells Segment by Type

Mogamulizumab

Lorvotuzumab Mertansine

Others

NK Cells Segment by Application

Cancer

Cardiovascular Diseases

Others

NK Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NK Cells market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of NK Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of NK Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. NK Cells Industry Trends Table 2. NK Cells Industry Drivers Table 3. NK Cells Industry Opportunities and Challenges Table 4. NK Cells Industry Restraints Table 5. Global NK Cells Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global NK Cells Revenue Market Share by Manufacturers (2021-2026) Table 7. Global NK Cells Sales by Manufacturers (g) & (2021-2026) Table 8. Global NK Cells Sales Market Share by Manufacturers Table 9. Global NK Cells Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global NK Cells Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global NK Cells Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global NK Cells Manufacturers, Product Type & Application Table 13. Global NK Cells Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global NK Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Mogamulizumab Table 17. Major Manufacturers of Lorvotuzumab Mertansine Table 18. Major Manufacturers of Others Table 19. Global NK Cells Sales by Type 2021 VS 2025 VS 2032 (g) Table 20. Global NK Cells Sales by Type (2021-2026) & (g) Table 21. Global NK Cells Sales by Type (2027-2032) & (g) Table 22. Global NK Cells Sales Market Share by Type (2021-2026) Table 23. Global NK Cells Sales Market Share by Type (2027-2032) Table 24. Global NK Cells Revenue by Type 2021 VS 2025 VS 2032 (g) Table 25. Global NK Cells Revenue by Type (2021-2026) & (g) Table 26. Global NK Cells Revenue by Type (2027-2032) & (g) Table 27. Global NK Cells Revenue Market Share by Type (2021-2026) Table 28. Global NK Cells Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cancer Table 30. Major Manufacturers of Cardiovascular Diseases Table 31. Major Manufacturers of Others Table 32. Global NK Cells Sales by Application 2021 VS 2025 VS 2032 (g) Table 33. Global NK Cells Sales by Application (2021-2026) & (g) Table 34. Global NK Cells Sales by Application (2027-2032) & (g) Table 35. Global NK Cells Sales Market Share by Application (2021-2026) Table 36. Global NK Cells Sales Market Share by Application (2027-2032) Table 37. Global NK Cells Revenue by Application 2021 VS 2025 VS 2032 (g) Table 38. Global NK Cells Revenue by Application (2021-2026) & (g) Table 39. Global NK Cells Revenue by Application (2027-2032) & (g) Table 40. Global NK Cells Revenue Market Share by Application (2021-2026) Table 41. Global NK Cells Revenue Market Share by Application (2027-2032) Table 42. Global NK Cells Sales by Region: 2021 VS 2025 VS 2032 (g) Table 43. Global NK Cells Sales by Region (2021-2026) & (g) Table 44. Global NK Cells Sales Market Share by Region (2021-2026) Table 45. Global NK Cells Sales Forecasted by Region (2027-2032) & (g) Table 46. Global NK Cells Sales Forecasted Market Share by Region (2027-2032) Table 47. North America NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 48. North America NK Cells Sales by Country (2021-2026) & (g) Table 49. North America NK Cells Sales by Country (2027-2032) & (g) Table 50. Europe NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 51. Europe NK Cells Sales by Country (2021-2026) & (g) Table 52. Europe NK Cells Sales by Country (2027-2032) & (g) Table 53. Asia Pacific NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 54. Asia Pacific NK Cells Sales by Country (2021-2026) & (g) Table 55. Asia Pacific NK Cells Sales by Country (2027-2032) & (g) Table 56. South America, Middle East and Africa NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (g) Table 57. South America, Middle East and Africa NK Cells Sales by Country (2021-2026) & (g) Table 58. South America, Middle East and Africa NK Cells Sales by Country (2027-2032) & (g) Table 59. Global NK Cells Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global NK Cells Revenue by Region (2021-2026) & (US$ Million) Table 61. Global NK Cells Revenue by Region (2027-2032) & (US$ Million) Table 62. Global NK Cells Revenue Market Share by Region (2021-2026) Table 63. Global NK Cells Revenue Market Share by Region (2027-2032) Table 64. Affimed NV Company Information Table 65. Affimed NV Business Overview Table 66. Affimed NV NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Affimed NV NK Cells Product Portfolio Table 68. Affimed NV Recent Development Table 69. Altor BioScience Company Information Table 70. Altor BioScience Business Overview Table 71. Altor BioScience NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Altor BioScience NK Cells Product Portfolio Table 73. Altor BioScience Recent Development Table 74. Chipscreen Biosciences Company Information Table 75. Chipscreen Biosciences Business Overview Table 76. Chipscreen Biosciences NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Chipscreen Biosciences NK Cells Product Portfolio Table 78. Chipscreen Biosciences Recent Development Table 79. Fortress Biotech Company Information Table 80. Fortress Biotech Business Overview Table 81. Fortress Biotech NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Fortress Biotech NK Cells Product Portfolio Table 83. Fortress Biotech Recent Development Table 84. Henry Ford Health Services Company Information Table 85. Henry Ford Health Services Business Overview Table 86. Henry Ford Health Services NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Henry Ford Health Services NK Cells Product Portfolio Table 88. Henry Ford Health Services Recent Development Table 89. Innate Pharma Company Information Table 90. Innate Pharma Business Overview Table 91. Innate Pharma NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Innate Pharma NK Cells Product Portfolio Table 93. Innate Pharma Recent Development Table 94. NantKwest Company Information Table 95. NantKwest Business Overview Table 96. NantKwest NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. NantKwest NK Cells Product Portfolio Table 98. NantKwest Recent Development Table 99. NKT Company Information Table 100. NKT Business Overview Table 101. NKT NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. NKT NK Cells Product Portfolio Table 103. NKT Recent Development Table 104. Sorrento Therapeutics Company Information Table 105. Sorrento Therapeutics Business Overview Table 106. Sorrento Therapeutics NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Sorrento Therapeutics NK Cells Product Portfolio Table 108. Sorrento Therapeutics Recent Development Table 109. Bristol-Myers Squibb Company Information Table 110. Bristol-Myers Squibb Business Overview Table 111. Bristol-Myers Squibb NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Bristol-Myers Squibb NK Cells Product Portfolio Table 113. Bristol-Myers Squibb Recent Development Table 114. Takeda Company Information Table 115. Takeda Business Overview Table 116. Takeda NK Cells Sales (g), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Takeda NK Cells Product Portfolio Table 118. Takeda Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. NK Cells Distributors List Table 122. NK Cells Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. NK Cells Product Image Figure 2. Global NK Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK Cells Market Size (2021-2032) & (US$ Million) Figure 4. Global NK Cells Sales (2021-2032) & (g) Figure 5. Global NK Cells Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 NK Cells Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Mogamulizumab Image Figure 9. Lorvotuzumab Mertansine Image Figure 10. Others Image Figure 11. Global NK Cells Sales by Type (2021 VS 2025 VS 2032) & (g) Figure 12. Global NK Cells Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global NK Cells Sales Market Share by Type (2021-2032) Figure 14. Global NK Cells Revenue by Type (2021 VS 2025 VS 2032) & (g) Figure 15. Global NK Cells Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global NK Cells Revenue Market Share by Type (2021-2032) Figure 17. Cancer Image Figure 18. Cardiovascular Diseases Image Figure 19. Others Image Figure 20. Global NK Cells Sales by Application (2021 VS 2025 VS 2032) & (g) Figure 21. Global NK Cells Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global NK Cells Sales Market Share by Application (2021-2032) Figure 23. Global NK Cells Revenue by Application (2021 VS 2025 VS 2032) & (g) Figure 24. Global NK Cells Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global NK Cells Revenue Market Share by Application (2021-2032) Figure 26. North America NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 27. North America NK Cells Sales Market Share by Country (2021-2032) Figure 28. U.S. NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 29. Canada NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 30. Mexico NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 31. Europe NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 32. Europe NK Cells Sales Market Share by Country (2021-2032) Figure 33. Germany NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 34. France NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 35. U.K. NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 36. Italy NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 37. Netherlands NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 38. Asia Pacific NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 39. Asia Pacific NK Cells Sales Market Share by Country (2021-2032) Figure 40. China NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 41. Japan NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 42. South Korea NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 43. Southeast Asia NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 44. India NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 45. Australia NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 46. South America, Middle East and Africa NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 47. South America, Middle East and Africa NK Cells Sales Market Share by Country (2021-2032) Figure 48. Brazil NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 49. South Africa NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 50. Saudi Arabia NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 51. Turkey NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 52. Argentina NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 53. UAE NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 54. Egypt NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 55. Chile NK Cells Sales and Growth Rate (2021-2032) & (g) Figure 56. Global NK Cells Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global NK Cells Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America NK Cells Revenue (2021-2032) & (US$ Million) Figure 59. North America NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe NK Cells Revenue (2021-2032) & (US$ Million) Figure 61. Europe NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific NK Cells Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa NK Cells Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. NK Cells Value Chain Figure 67. Manufacturing Cost Structure Figure 68. NK Cells Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Applications
  • Cancer
  • Cardiovascular Diseases
  • Others
Companies covered
  • Affimed NV
  • Altor BioScience
  • Chipscreen Biosciences
  • Fortress Biotech
  • Henry Ford Health Services
  • Innate Pharma
  • NantKwest
  • NKT
  • Sorrento Therapeutics
  • Bristol-Myers Squibb
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NK Cells Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NK Cells Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global NK Cells Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global NK Cells Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global NK Cells Market Dynamics
  1. 2.1 NK Cells Industry Trends
  2. 2.2 NK Cells Industry Drivers
  3. 2.3 NK Cells Industry Opportunities and Challenges
  4. 2.4 NK Cells Industry Restraints
3 NK Cells Market by Manufacturers
  1. 3.1 Global NK Cells Revenue by Manufacturers (2021-2026)
  2. 3.2 Global NK Cells Sales by Manufacturers (2021-2026)
  3. 3.3 Global NK Cells Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global NK Cells Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NK Cells Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global NK Cells Manufacturers, Product Type & Application
  7. 3.7 Global NK Cells Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NK Cells Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NK Cells Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NK Cells Tier 1, Tier 2, and Tier 3
4 NK Cells Market by Type
  1. 4.1 NK Cells Type Introduction
  2. 4.1.1 Mogamulizumab
  3. 4.1.2 Lorvotuzumab Mertansine
  4. 4.1.3 Others
  5. 4.2 Global NK Cells Sales by Type
  6. 4.2.1 Global NK Cells Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global NK Cells Sales by Type (2021-2032)
  8. 4.2.3 Global NK Cells Sales Market Share by Type (2021-2032)
  9. 4.3 Global NK Cells Revenue by Type
  10. 4.3.1 Global NK Cells Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global NK Cells Revenue by Type (2021-2032)
  12. 4.3.3 Global NK Cells Revenue Market Share by Type (2021-2032)
5 NK Cells Market by Application
  1. 5.1 NK Cells Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Cardiovascular Diseases
  4. 5.1.3 Others
  5. 5.2 Global NK Cells Sales by Application
  6. 5.2.1 Global NK Cells Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NK Cells Sales by Application (2021-2032)
  8. 5.2.3 Global NK Cells Sales Market Share by Application (2021-2032)
  9. 5.3 Global NK Cells Revenue by Application
  10. 5.3.1 Global NK Cells Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NK Cells Revenue by Application (2021-2032)
  12. 5.3.3 Global NK Cells Revenue Market Share by Application (2021-2032)
6 Global NK Cells Sales by Region
  1. 6.1 Global NK Cells Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NK Cells Sales by Region (2021-2032)
  3. 6.2.1 Global NK Cells Sales by Region (2021-2026)
  4. 6.2.2 Global NK Cells Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America NK Cells Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe NK Cells Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific NK Cells Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa NK Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa NK Cells Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global NK Cells Revenue by Region
  1. 7.1 Global NK Cells Revenue by Region
  2. 7.1.1 Global NK Cells Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global NK Cells Revenue by Region (2021-2026)
  4. 7.1.3 Global NK Cells Revenue by Region (2027-2032)
  5. 7.1.4 Global NK Cells Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America NK Cells Revenue (2021-2032)
  8. 7.2.2 North America NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe NK Cells Revenue (2021-2032)
  11. 7.3.2 Europe NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific NK Cells Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa NK Cells Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa NK Cells Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Affimed NV
  2. 8.1.1 Affimed NV Company Information
  3. 8.1.2 Affimed NV Business Overview
  4. 8.1.3 Affimed NV NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Affimed NV NK Cells Product Portfolio
  6. 8.1.5 Affimed NV Recent Developments
  7. 8.2 Altor BioScience
  8. 8.2.1 Altor BioScience Company Information
  9. 8.2.2 Altor BioScience Business Overview
  10. 8.2.3 Altor BioScience NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Altor BioScience NK Cells Product Portfolio
  12. 8.2.5 Altor BioScience Recent Developments
  13. 8.3 Chipscreen Biosciences
  14. 8.3.1 Chipscreen Biosciences Company Information
  15. 8.3.2 Chipscreen Biosciences Business Overview
  16. 8.3.3 Chipscreen Biosciences NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chipscreen Biosciences NK Cells Product Portfolio
  18. 8.3.5 Chipscreen Biosciences Recent Developments
  19. 8.4 Fortress Biotech
  20. 8.4.1 Fortress Biotech Company Information
  21. 8.4.2 Fortress Biotech Business Overview
  22. 8.4.3 Fortress Biotech NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fortress Biotech NK Cells Product Portfolio
  24. 8.4.5 Fortress Biotech Recent Developments
  25. 8.5 Henry Ford Health Services
  26. 8.5.1 Henry Ford Health Services Company Information
  27. 8.5.2 Henry Ford Health Services Business Overview
  28. 8.5.3 Henry Ford Health Services NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Henry Ford Health Services NK Cells Product Portfolio
  30. 8.5.5 Henry Ford Health Services Recent Developments
  31. 8.6 Innate Pharma
  32. 8.6.1 Innate Pharma Company Information
  33. 8.6.2 Innate Pharma Business Overview
  34. 8.6.3 Innate Pharma NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Innate Pharma NK Cells Product Portfolio
  36. 8.6.5 Innate Pharma Recent Developments
  37. 8.7 NantKwest
  38. 8.7.1 NantKwest Company Information
  39. 8.7.2 NantKwest Business Overview
  40. 8.7.3 NantKwest NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NantKwest NK Cells Product Portfolio
  42. 8.7.5 NantKwest Recent Developments
  43. 8.8 NKT
  44. 8.8.1 NKT Company Information
  45. 8.8.2 NKT Business Overview
  46. 8.8.3 NKT NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NKT NK Cells Product Portfolio
  48. 8.8.5 NKT Recent Developments
  49. 8.9 Sorrento Therapeutics
  50. 8.9.1 Sorrento Therapeutics Company Information
  51. 8.9.2 Sorrento Therapeutics Business Overview
  52. 8.9.3 Sorrento Therapeutics NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sorrento Therapeutics NK Cells Product Portfolio
  54. 8.9.5 Sorrento Therapeutics Recent Developments
  55. 8.10 Bristol-Myers Squibb
  56. 8.10.1 Bristol-Myers Squibb Company Information
  57. 8.10.2 Bristol-Myers Squibb Business Overview
  58. 8.10.3 Bristol-Myers Squibb NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bristol-Myers Squibb NK Cells Product Portfolio
  60. 8.10.5 Bristol-Myers Squibb Recent Developments
  61. 8.11 Takeda
  62. 8.11.1 Takeda Company Information
  63. 8.11.2 Takeda Business Overview
  64. 8.11.3 Takeda NK Cells Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Takeda NK Cells Product Portfolio
  66. 8.11.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NK Cells Value Chain Analysis
  2. 9.1.1 NK Cells Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NK Cells Production Mode & Process
  6. 9.2 NK Cells Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NK Cells Distributors
  9. 9.2.3 NK Cells Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst